Detalhe da pesquisa
1.
Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Blood;
143(14): 1379-1390, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38142436
2.
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Blood;
142(5): 477-492, 2023 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37216687
3.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood;
141(16): 1971-1981, 2023 04 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36626583
4.
Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Blood;
140(18): 1951-1963, 2022 11 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35921533
5.
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Blood;
139(10): 1541-1556, 2022 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34818414
6.
Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia.
Cytotherapy;
2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38804991
7.
Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Int J Clin Oncol;
29(2): 232-240, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38157190
8.
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.
Br J Haematol;
201(6): 1144-1152, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37067758
9.
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.
Ann Hematol;
102(11): 3103-3113, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37597110
10.
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Eur J Haematol;
111(4): 620-627, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37465857
11.
Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.
Int J Clin Oncol;
28(6): 816-826, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37071252
12.
[CAR-T therapy for adult B-cell acute lymphoblastic leukemia].
Rinsho Ketsueki;
64(11): 1432-1439, 2023.
Artigo
em Japonês
| MEDLINE
| ID: mdl-38072431
13.
[Management of adverse effects in CAR T-cell therapy].
Rinsho Ketsueki;
64(9): 1203-1212, 2023.
Artigo
em Japonês
| MEDLINE
| ID: mdl-37899201
14.
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort.
Cancer Sci;
113(12): 4267-4276, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36052883
15.
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.
Int J Clin Oncol;
27(1): 213-223, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34599413
16.
[Clinical development of chimeric antigen receptor T-cell therapy in multiple myeloma].
Rinsho Ketsueki;
63(6): 580-588, 2022.
Artigo
em Japonês
| MEDLINE
| ID: mdl-35831191
17.
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B-cell lymphoma.
Cancer Sci;
112(7): 2845-2854, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33942442
18.
High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease.
Ann Hematol;
100(5): 1321-1328, 2021 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33215225
19.
Hetero-Type Benzannulation Leading to Substituted Benzothio-Phenes.
Molecules;
26(22)2021 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34834100
20.
[Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
Rinsho Ketsueki;
62(11): 1609-1614, 2021.
Artigo
em Japonês
| MEDLINE
| ID: mdl-34866084